Trastuzumab emtansine (T-DM1) renders HER2(+) breast cancer highly susceptible to CTLA-4/PD-1 blockade
Publication status
publishedExternal links
Journal / series
Science Translational MedicineVolume
Pages / Article No.
Publisher
AAASOrganisational unit
03952 - Reddy, Sai / Reddy, Sai
More
Show all metadata